focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Wall Street kicks off August on the plus side

Mon, 02nd Aug 2021 15:41

* U.S. equity indexes higher, Dow out front, chips strong

* Financials lead S&P sector gainers; staples weakest group

* Euro STOXX 600 index up ~0.5%

* Gold flat; dollar, crude, bitcoin all dip

* U.S. 10-Year Treasury yield ~1.19%

Aug 2 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

WALL STREET KICKS OFF AUGUST ON THE PLUS SIDE (1022 EDT/1422
GMT)

Major U.S. averages came out of the gate in August, usually
among the weaker and more volatile months, with solid gains led
by a rise of more than 1% in both the energy and
financial sectors.

Stocks posted a muted reaction to economic data released a
short time ago, which saw the final July manufacturing reading
from Markit come in at 63.4, a touch higher than the flash
reading of 63.1. However, data on the manufacturing sector from
the Institute for Supply Management showed activity slowed to
59.5 in July, shy of the 60.9 expectation and the lowest since
January.

Among the top boosts to the S&P 500 in early trading
are Tesla, JP Morgan, and Pfizer, while
Facebook, Apple and Global Payments are
the biggest drags on the benchmark index.

Below is your market snapshot:

(Chuck Mikolajczak)

*****

WHEN M&A IS MADE IN BRITAIN (0914 EDT/1314 GMT)

The U.S. takeover of engineer Meggitt is just the
latest in a series of M&A moves targeting Britain recently.

Morrison, Ultra, Vectura and Sanne
are other examples but beyond the market moving
headlines hard data also backs the view that Britain has proved
a particularly fertile ground for M&A this year.

Cross-border M&A with a UK target has increased by 340% to
$132.5 billion year to date, the latest Refintiv data to
end-July show. That's about nine times the 39% growth seen in
Europe and well above growth in the Americas (+200%) and Asia
(+182%).

"Now after all the fear mongering post Brexit has been
proven wrong UK companies are certainly of interest," says a
London-based trader. "Many companies and also Private Equity too
are looking to diversify in regard to location and are often
underinvested in the UK".

And beyond the volumes, investors in UK Plc appear to like
it, whereas it is becoming harder for acquirers to get a bargain
even though British companies are not necessarily overvalued at
this stage.

Meggitt shares shot up more than 60% this morning and that
in turn has helped the domestically focused mid-cap and FTSE 250
index race to a new record high.

"I am quite impressed by the massive premium which is being
paid for Meggitt," says the trader.

And AJ Bell investment director Russ Mould notes: "Private
equity firms have a reputation for trying to get a bargain, but
their tactics have been fully exposed this year and it now seems
rare for the first offer to be the winning one."

For more reading: BREAKINGVIEWS-UK plc’s latest sale is far
from on the cheap

(Danilo Masoni)

*****

S&P 500: FROM BULLISH FODDER TO BEARISH DUST? (0900 EDT/1300
GMT)

Amid on-going Federal Reserve support, the economic
re-opening, S&P 500 Q2 2021 year-over-year earnings
growth running at nearly 90%, and now a $1 trillion
infrastructure bill unveiled by U.S. Senators raising hopes of
more fiscal stimulus, there certainly is plenty of fodder for
bulls to be excited about.

So far, the S&P 500 index's record closing high was
on Monday July 26. Since then the benchmark index has
essentially chopped sideways, ending Friday just around 0.6%
below that high.

With this, however, a contrarian measure of sentiment, based
on the CBOE equity put/call (P/C) ratio, is exhibiting a pattern
that has preceded periods of market instability:

With the SPX's all-time high close, the 5-day moving average
of the P/C ratio fell to 41.6%. This put it just slightly above
its relatively recent, multi-decade lows. This measure's
depressed readings can flag an excessively bullish, or
especially complacent market, vulnerable to a reversal.

Indeed, what may be a more robust bearish signal is when the
moving average puts in a higher-low, against a higher SPX high.
This pattern developed ahead of declines of varying degree over
the last two years or so, including the severe sell-offs in late
2018 and early 2020.

In the wake of its 37.6% December 7 trough, which was its
lowest reading since around the time of the Y2K tech-bubble
peak, the measure has put in higher lows at 37.8% on January 14,
38.4% on February 11, and 39.6% on June 14. It has since vaulted
to 54.2%, despite just a modest drop in the index.

Thus, this measure may be signaling cracks are forming in
what has been solidly bullish sentiment. If so, instability may
be just around the corner.

(Terence Gabriel)

*****

FOR MONDAY'S LIVE MARKETS' POSTS PRIOR TO 0900 EDT/1300 GMT
- CLICK HERE:

(Terence Gabriel is a Reuters market analyst. The views
expressed are his own)

More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.